Obstructive Sleep Apnoea,Cigarette Smoking and Plasma Orexin-A in a Sleep Clinic Cohort

Abstract

Orexin-A is a neuropeptide involved in the regulation of food intake and the sleep-wake cycle. This study investigated plasma orexin-A levels in a sleep clinic cohort, adjusting for smoking habits, in 76 participants comprising 41 with obstructive sleep apnoea (OSA) (apnoea-hypopnoea index [AHI] 44.1 ± 19.1 events/h) and 35 without OSA (AHI 6.3 ± 4.7 events/h). Plasma orexin-A levels were significantly lower in OSA patients (15.0 ± 4.6 ng/ml) compared with those without OSA (31.4 ± 6.5 ng/ml). In non-OSA subjects, there was no significant difference between never smokers and ex/current smokers in plasma orexin-A levels (32.9 ± 9.5 versus 29.7 ± 8.9 ng/ml, respectively) whereas, in the OSA sub-group, orexin-A levels were significantly lower in never smokers than in ex/current smokers (4.0 ± 1.2 versus 21.4 ± 7.0 ng/ml). A significant inverse relationship was found between plasma orexin-A levels and AHI amongst never smokers, but there was no significant relationship amongst ex/current smokers. These results confirm previous studies demonstrating lower levels of plasma orexin-A in OSA patients and indicate that smoking may affect orexin-A levels and AHI.

Keywords

Obstructive sleep apnoea Orexin-A Cigarette smoking Apnoea-hypopnoea index

References

Young

Peppard

Gottlieb

: Epidemiology of obstructive sleep apnea: A population health perspective. Am J Respir Crit Care Med 2002; 165: 1217–1239.

Peker

Hedner

Norum

: Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: A 7-year follow-up. Am J Respir Crit Care Med 2002; 166: 159–165.

Taheri

Ward

Ghatei

: Role of orexins in sleep and arousal mechanisms. Lancet 2000; 355: 847.

Sutcliffe

de Lecea

: The hypocretins: Excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J Neurosci Res 2000; 62: 161–168.

Nishijima

Sakurai

Arihara

: Plasma orexin-A-like immunoreactivity in patients with sleep apnea hypopnea syndrome. Peptides 2003; 24: 407–411.

Sakurai

Nishijima

Takahashi

: Clinical significance of daytime plasma orexin-A-like immunoreactivity concentrations in patients with obstructive sleep apnea hypopnea syndrome. Respiration 2004; 71: 380–384.

Busquets

Barbe

Barcelo : Decreased plasma levels of orexin-A in sleep apnea. Respiration 2004; 71: 575–579.

Igarashi

Tatsumi

Nakamura

: Plasma orexin-A levels in obstructive sleep apnea-hypopnea syndrome. Chest 2003; 124: 1381–1385.

Sakurai

Nishijima

Takahashi

: Low plasma orexin-A levels were improved by continuous positive airway pressure treatment in patients with severe obstructive sleep apnea-hypopnea syndrome. Chest 2005; 127: 731–737.

10.

Adam

Menheere

van Dielen

: Decreased plasma orexin-A levels in obese individuals. Int J Obes Relat Metab Disord 2002; 26: 274–276.

11.

Matsumura

Nakayama

Nomura

: Age-related changes in plasma orexin-A concentrations. Exp Gerontol 2002; 37: 1127–1130.

12.

Schrand

: Is sleep apnea a predisposing factor for tobacco use?. Med Hypotheses 1996; 47: 443–448.

13.

Kashyap

Hock

Bowman

: Higher prevalence of smoking in patients diagnosed as having obstructive sleep apnea. Sleep Breath 2001; 5: 167–172.

14.

Hoffstein

: Relationship between smoking and sleep apnea in clinic population. Sleep 2002; 25: 519–524.

15.

Casasola

Alvarez-Sala

Marques

: Smoking behaviour and respiratory alterations during sleep in a healthy population. Sleep Breath 2002; 6: 19–24.

16.

Jarvik

: Beneficial effects of nicotine. Br J Addict 1991; 86: 571–575.

17.

Davila

Hurt

Offord

: Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. Am J Respir Crit Care Med 1994; 150: 469–474.

18.

Lavie

: Smoking interacts with sleep apnea to increase cardiovascular risk. Sleep Med 2008; 9: 247–253.

19.

Kane

Parker

Matta

: Nicotine upregulates expression of orexin and its receptors in rat brain. Endocrinology 2000; 141: 3623–3629.

20.

Johns

: A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep 1991; 14: 540–545.

21.

Rechtschaffen

Kales

, (eds): A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subject. Washington DC: US Government Printing Office, National Institute of Health Publication, 1968.

22.

Lavie

Herer

Hoffstein

: Obstructive sleep apnoea syndrome as a risk factor for hypertension: Population study. BMJ 2000; 320: 479–482.

23.

Hagan

Leslie

Patel

: Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 1999; 96: 10911–10916.

24.

Morales

Chase

: Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat. Brain Res 2001; 901: 259–264.

25.

Piper

Upton

Smith

: The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur J Neurosci 2000; 12: 726–730.

26.

Methippara

Alam

Szymusiak

: Effects of lateral preoptic area application of orexin-A on sleep-wakefulness. Neuroreport 2000; 11: 3423–3426.

27.

Sartin

Dyer

Matteri

: Effect of intracerebroventricular orexin-B on food intake in sheep. J Anim Sci 2001; 79: 1573–1577.

28.

Schwartz

: Orexins and appetite: The big picture of energy homeostasis gets a little bigger. Nat Med 1998; 4: 385–386.

29.

Kotz

Teske

Levine

: Feeding and activity induced by orexin-A in the lateral hypothalamus in rats. Regul Pept 2002; 104: 27–32.

30.

Isse

Ueta

Serino

: Effects of leptin on fasting-induced inhibition of neuronal nitric oxide synthase mRNA in the paraventricular and supraoptic nuclei of rats. Brain Res 1999; 846: 229–235.

31.

López

Seoane

Garcia

: Leptin regulation of prepro-orexin-A and orexin-A receptor mRNA levels in the hypothalamus. Biochem Biophys Res Commun 2000; 269: 41–45.

32.

Vgontzas

Papanicolaou

Bixler

: Sleep apnea and daytime sleepiness and fatigue: Relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000; 85: 1151–1158.

33.

Bronsky

Nedvidkova

Zamrazilova

: Dynamic changes of orexin-A and leptin in obese children during body weight reduction. Physiol Res 2007; 56: 89–96.

34.

Sugimoto

Nagake

Sugimoto

: Plasma orexin concentrations in patients on hemodialysis. Nephron 2002; 90: 379–383.

35.

Cai

Widdowson

Harrold

: Hypothalamic orexin expression: Modulation by blood glucose and feeding. Diabetes 1999; 48: 2132–2137.

36.

Higuchi

Usui

Murasaki

: Plasma orexin-A is lower in patients with narcolepsy. Neurosci Lett 2002; 318: 61–64.

37.

Matsumura

Nakayama

Satoh

: Plasma orexin-A levels and body composition in COPD. Chest 2003; 123: 1060–1065.